News | May 02, 2026
Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
The transaction marks a clear portfolio reshuffle for Indoco
The transaction marks a clear portfolio reshuffle for Indoco
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Subscribe To Our Newsletter & Stay Updated
